This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Viventia Bio Inc.

Drug Names(s): VB6845d, VB6 845d

Description: VB6-845d is a targeted protein therapeutic (TPT) consisting of an EpCAM targeting Fab antibody fragment genetically fused to the de-immunized cytotoxic protein payload, deBouganin.

VB6-845d News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug